The Pharmaceutical Contract Packaging Market is estimated to be valued at USD 7.0 billion in 2025 and is projected to reach USD 14.0 billion by 2035, registering a compound annual growth rate (CAGR) of 7.1% over the forecast period.
| Metric | Value |
|---|---|
| Pharmaceutical Contract Packaging Market Estimated Value in (2025 E) | USD 7.0 billion |
| Pharmaceutical Contract Packaging Market Forecast Value in (2035 F) | USD 14.0 billion |
| Forecast CAGR (2025 to 2035) | 7.1% |
The pharmaceutical contract packaging market is experiencing robust growth. Rising demand for outsourced packaging solutions, increasing regulatory requirements, and a growing pharmaceutical pipeline are driving market expansion. Current dynamics are shaped by the need for specialized packaging formats that ensure product stability, compliance, and patient safety.
Technological advancements in packaging materials, automation, and serialization have improved efficiency and reduced errors. The future outlook is influenced by the rising prevalence of chronic diseases, expansion of biologics and specialty drugs, and increasing focus on patient-centric packaging.
Growth rationale is grounded in the ability of contract packaging providers to offer flexible, scalable, and compliant solutions Strategic collaborations with pharmaceutical manufacturers and continuous innovation in packaging design and materials are expected to enhance operational efficiency and reliability, thereby enabling sustained adoption across multiple therapeutic categories and global markets.
The flexible packaging segment, holding 36.4% of the product type category, has been leading due to its adaptability, cost efficiency, and protective properties. Its adoption has been reinforced by the ability to accommodate varied dosage forms, extend shelf life, and ensure compliance with regulatory standards.
Market growth has been supported by technological improvements in barrier films, lamination, and printing, which enhance product integrity and brand differentiation. Manufacturers have focused on optimizing supply chains, reducing material waste, and implementing sustainable packaging practices, which have strengthened market confidence.
Continued innovation in flexible packaging solutions, including child-resistant, tamper-evident, and easy-to-use designs, is expected to maintain the segment’s market share and drive incremental adoption across both branded and generic pharmaceutical products.
The oral segment, representing 58.7% of the form type category, has maintained dominance due to widespread preference for oral dosage forms in therapeutic administration. Adoption has been supported by high patient compliance, ease of manufacturing, and compatibility with multiple packaging formats.
Regulatory requirements for labeling, serialization, and tamper evidence have reinforced the need for specialized contract packaging solutions. Technological enhancements in blister packs, bottles, and sachets have improved safety, stability, and convenience.
Continued focus on innovative packaging that supports adherence, extended shelf life, and operational efficiency is expected to sustain the segment’s market share and strengthen its contribution to overall market growth.
The cancer therapies segment, accounting for 24.5% of the application type category, has emerged as a leading application due to increasing oncology drug development and the complexity of therapeutic regimens. Adoption has been supported by the need for precise dosing, protective packaging to maintain drug stability, and compliance with regulatory and safety standards.
Market growth has been reinforced by the expansion of personalized medicine and specialty oncology treatments, which demand high-quality packaging solutions. Contract packaging providers have focused on advanced materials, serialization, and traceability to meet the stringent requirements of cancer therapies.
These factors are expected to sustain the segment’s market share and support continued demand across global pharmaceutical markets.
Establishing mutually beneficial relationships with contract packaging organizations (CPOs) to avoid a lack of resources and budgets is driving the pharmaceutical contract packaging market growth. Furthermore, it is anticipated to rise with the implementation of serialization that mandates the barcodes and transfer of data in the supply of medicines.
The rising prevalence of atmosphere-sensitive pharmaceutical drugs has surged the demand for silica-based packaging material as the latest pharmaceutical contract packaging market trend. Moreover, a proliferation of the geriatric population in developed regions highly dependent on pharmaceutical drugs is projected to boost the sales of pharmaceutical contract packaging.
Key Pharmaceutical Contract Packaging Market Dynamics
New treatments such as gene and cell therapies, and growing demand for bio-products are some of the factors driving the adoption of pharmaceutical contract packaging. The capability of vendors to undertake several packaging projects, including sorting issues arising from complex packaging requirements surges the adoption of pharmaceutical contract packaging.
Government execution of new regulations to control the quality of pharmaceutical products available in the market is driving innovations in pharmaceutical product packaging and labeling. Generic pharmaceuticals of lower cost increasing in popularity and requiring efficient packaging and protection during storage and shipping is projected to boost the demand further.
Drawbacks in the Pharmaceutical Contract Packaging
Fluctuating prices of raw materials used for manufacturing pharmaceutical packaging products are some of the factors anticipated to hamper the market growth. Increasing risks associated with the poor quality of the product as well as design could also compromise the credibility of the pharmaceutical packaging market.
The availability of counterfeit medicines containing false or inactive ingredients across the globe significantly hinders the growth opportunity for the pharmaceutical packaging industry. On top of that, the lack of expertise of employees for effective in-house packaging capabilities, and budget constraints further obstruct the outsourcing trends in pharmaceutical packaging.
North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America.
Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size.
Europe holds a 28% revenue in the pharmaceutical contract packaging market share and is the second most dominating market. Germany was figured out to be leading in terms of the production of assets for the establishment of pharmaceutical contract packaging industries. Over the years from 2025 to 2035, the regional market is expected to advance at a rate of 5% per year.
A large presence of major manufacturers operating in the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing the use of plastic bottles and containers, vials & ampoules, and pre-fillable syringes could also boost the demand for pharmaceutical contract packaging in this region.
The Asia Pacific is anticipated to grow at a remarkable CAGR in pharmaceutical contract packaging services and products in the coming days. China is the leading market hear that is poised to exhibit a year-on-year increment of 8.7% from 2025 to 2035.
Increasing demand for biological therapies and rigid protocols associated with packaging processes have created a huge demand for outsourced pharmaceutical packaging in the country. In addition to this, the presence of several pharmaceutical contract packaging service providers in the region has boosted the overall market size in the past.
The sales of pharmaceutical contract packaging are anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India. India, in particular, is anticipated to exhibit a lucrative growth rate of 9.1% over the forecast years.
In the table below we have represented the regional growth rates of different countries in pharmaceutical contract packaging. Though the countries in North America and Europe lead the global business, the emerging economies promise greater opportunities in this industry.
| Regional Market Comparison | CAGR (2025 to 2035) |
|---|---|
| United States | 4.8% |
| Germany | 5% |
| United Kingdom | 6.4% |
| India | 9.1% |
| China | 8.7% |
To protect pharmaceutical products better than conventional materials, startups in pharmaceutical contract packaging strive to develop enhanced packaging solutions. This is changing the landscape of pharmaceutical contact packaging and generating newer and more innovative ideas to tackle every challenge.
Hence, some start-up companies such as Veneti, Unipharm Healthy Manufacturing, V-Shapes, Blistr, Calyx Containers, etc. are coming up with various strategies to scale their business. They are mostly resorting to novel solutions like medical cannabis containers, biodegradable pharma packaging, single-portion packets, contract pharmaceutical packaging with labeling and distribution, etc.
Some of the recent developments in pharmaceutical contract packaging are
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.5% from 2025 to 2035 |
| The base year for estimation | 2025 |
| Historical data | 2020 to 2025 |
| Forecast period | 2025 to 2035 |
| Quantitative units | Revenue in USD million or billion and CAGR from 2025 to 2035 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments Covered | By Type, By Form, By Application, and By Region. |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East and Africa (MEA); ASEAN; South Asia; Rest of Asia; Australia; and New Zealand |
| Country scope | United States of America, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Catalent Pharma Solutions; Patheon; Baxter BioPharma Solutions; AbbVie Contract Manufacturing; Pfizer Centre Source; Daito Pharmaceutical; Nipro Corporation; Becton Dickinson & Company; AptarGroup Inc.; Drug Plastics Group; Gerresheimer AG; Schott AG; Owens Illinois Inc.; WestRock Company SGD S.A.; International Paper Company; COMAR LLC; CCL Industries Inc.; Vetter Pharma International; Adelphi Healthcare Packaging; Sharp Corporation; Amcor Limited; Berry Plastics Corporation; MeadWestvaco Corporation; Becton Dickinson and Company; Owens-Illinois Inc.; West Pharmaceuticals Services Inc.; Schott Pharmaceuticals Services Inc.; RPC Group Plc; Graphic Packaging International Inc.; etc. |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The global pharmaceutical contract packaging market is estimated to be valued at USD 7.0 billion in 2025.
The market size for the pharmaceutical contract packaging market is projected to reach USD 14.0 billion by 2035.
The pharmaceutical contract packaging market is expected to grow at a 7.1% CAGR between 2025 and 2035.
The key product types in pharmaceutical contract packaging market are flexible packaging, plastic or glass containers and caps or closures.
In terms of form type, oral segment to command 58.7% share in the pharmaceutical contract packaging market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Market Share Insights for Pharmaceutical Contract Packaging Providers
Pharmaceutical Manufacturing Equipment Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Plastic Bottle Market Forecast and Outlook 2025 to 2035
Pharmaceutical Grade Sodium Carbonate Market Forecast and Outlook 2025 to 2035
Pharmaceutical Industry Analysis in Saudi Arabia Forecast and Outlook 2025 to 2035
Pharmaceutical Grade Sodium Chloride Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Plastic Pots Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceuticals Pouch Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Mini Batch Blender Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Continuous Manufacturing Equipment Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Liquid Prefilters Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Grade P-Toluenesulfonic Acid Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Glass Container Industry Analysis in Europe Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Container Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Sterility Testing Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceuticals Preservative Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Track and Trace Systems Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Vials Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceuticals Machinery Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Logistics Market Size and Share Forecast Outlook 2025 to 2035
Pharmaceutical Contract Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
